Clarity's groundbreaking approach is the first to deliver 40Hz gamma-frequency light and sound stimulation via virtual reality (VR) technology to address key pathophysiological markers of Alzheimer’s disease (AD), including neuroinflammation and synaptic dysfunction. These results set the stage for a new category of non-invasive, disease-modifying therapies.